|
|
| Glaxo SmithKline Pharmaceuticals Limited |
|
Financials-Glaxo SmithKline Pharmaceuticals Limited| Sector: Formulations | | BSE:500660 | NSE:GLAXO | Bloomberg:GLXO@IN | Reuters:GLAX.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE159A01016 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
30-Jun-2021(3) |
30-Jun-2020(3) |
% Change |
| Sales of Products/Services |
7734.60 |
6486.50 |
19.24 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
317.30 |
577.90 |
-45.09 |
| Total Income |
8051.90 |
7064.40 |
13.98 |
| Total Expenses |
-6412.70 |
-5571.50 |
15.10 |
| OPBDIT |
14464.60 |
12635.90 |
14.47 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-177.10 |
-5571.50 |
-96.82 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-435.20 |
-383.30 |
13.54 |
| After Tax Profit |
1204.00 |
1109.60 |
8.51 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Dec-07(12) |
|
31-Dec-06(12) |
|
31-Dec-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
15702.98 |
96.25 |
15384.23 |
97.14 |
14703.82 |
97.88 |
| Operating Income (OI) |
16315.18 |
100.00 |
15836.76 |
100.00 |
15021.63 |
100.00 |
| OPBDIT |
5591.58 |
34.27 |
5120.13 |
32.33 |
4604.77 |
30.65 |
| OPBDT |
5578.04 |
34.19 |
5105.27 |
32.24 |
4584.81 |
30.52 |
| OPBT |
5416.44 |
33.20 |
4946.74 |
31.24 |
4427.48 |
29.47 |
| Non-Operating Income |
695.30 |
4.26 |
612.80 |
3.87 |
351.60 |
2.34 |
| Extraordinary/Prior Period |
1257.84 |
7.71 |
1784.59 |
11.27 |
1794.50 |
11.95 |
| Tax |
1993.00 |
12.22 |
1889.00 |
11.93 |
1552.76 |
10.34 |
| Profit after tax(PAT) |
5376.59 |
32.95 |
5455.13 |
34.45 |
5020.83 |
33.42 |
| Cash Profit |
5538.18 |
33.94 |
5613.66 |
35.45 |
5178.16 |
34.47 |
| Dividend-Equity |
3049.31 |
18.69 |
2625.79 |
16.58 |
2371.68 |
15.79 |
|
| As on |
31-Dec-07 |
|
31-Dec-06 |
|
31-Dec-05 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
2667.08 |
13.24 |
2536.27 |
14.28 |
2359.32 |
15.65 |
| Net Block |
874.73 |
4.34 |
858.01 |
4.83 |
758.36 |
5.03 |
| Capital WIP |
54.30 |
0.27 |
86.61 |
0.49 |
153.73 |
1.02 |
| Investments |
6692.86 |
33.23 |
7379.92 |
41.54 |
3743.98 |
24.84 |
| Inventory |
2059.63 |
10.23 |
2409.54 |
13.56 |
2181.29 |
14.47 |
| Receivables |
377.66 |
1.88 |
604.45 |
3.40 |
673.87 |
4.47 |
| Other Current Assets |
10079.05 |
50.05 |
6428.42 |
36.18 |
7561.20 |
50.17 |
| Balance Sheet Total(BT) |
20138.23 |
100.00 |
17766.95 |
100.00 |
15072.44 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
847.03 |
4.21 |
847.03 |
4.77 |
847.03 |
5.62 |
| Reserves |
12762.14 |
63.37 |
11100.10 |
62.48 |
8581.69 |
56.94 |
| Total Debt |
57.67 |
0.29 |
55.37 |
0.31 |
48.54 |
0.32 |
| Creditors and Acceptances |
2262.98 |
11.24 |
2306.35 |
12.98 |
2374.56 |
15.75 |
| Other current liab/prov. |
4208.42 |
20.90 |
3458.10 |
19.46 |
3220.62 |
21.37 |
| Balance Sheet Total(BT) |
20138.23 |
100.00 |
17766.95 |
100.00 |
15072.44 |
100.00 |
|
| As on |
31-Dec-07 |
31-Dec-06 |
31-Dec-05 |
| OPBIT/Prod.cap.empl.(%) |
1944.04 |
950.80 |
2304.85 |
| PBIT/Cap. Employed (%) |
54.24 |
61.76 |
70.72 |
| PAT/Networth (%) |
39.51 |
45.66 |
53.25 |
| Tax/PBT (%) |
27.04 |
25.72 |
23.62 |
| Total Debt/Networth (x) |
0.00 |
0.00 |
0.01 |
| Long Term Debt/Networth (x) |
0.00 |
0.00 |
0.00 |
| PBDIT/Finance Charges (x) |
557.09 |
506.16 |
338.37 |
| Current Ratio (x) |
1.93 |
1.64 |
1.86 |
| RM Inventory (days consumption) |
82.06 |
95.01 |
97.91 |
| FG inventory (days cost of sales) |
44.22 |
54.41 |
52.01 |
| Receivables (days gross sales) |
8.05 |
13.15 |
15.61 |
| Creditors (days cost of sales) |
77.03 |
78.55 |
83.20 |
| Op. curr. assets (days OI) |
125.00 |
117.00 |
112.00 |
|
|
Financials